Skip to main content

Table 3 Phosphatidylethanolamine-based radiolabelled molecular imaging probes

From: Transbilayer phospholipids molecular imaging

Molecular target

Molecular probes

AA

MW (kDa)

Affinity (M)

Biological functions

Isotopes

Imaging techniques

PE

duramycin

19

2

10-9

apoptosis

necrosis

99mTc a

SPECT(CT)

PE

ethanolamine

N'N-dimethyl ethanolamine

-

-

-

ethanolamine metabolism (tumour proliferation)

14C b

PET(CT)

PE c

hypericin

-

0.504

-

necrosis

123I, 131I 99mTc

SPECT(CT)

      

64Cu d

PET(CT)

  1. a HYNIC has been used as a bifunctional chelating agent for the radiolabelling of duramycin. b ethanolamine or N,N'-dimethylethanolamine labelled with 14C in preclinical in vitro research may be labelled with 11C or 18F for PET(CT) in vivo imaging. c 64Cu-bis-DOTA-hypericin has a selective binding affinity for PS and PE (ref.45); it may be hypothesised that 123I-, 131I- and 99mTc-labelled hypericin derivatives bind to PS and PE. d bis-DOTA has been used as a bifunctional chelating agent for the radiolabelling of hypericin. AA, amino acids; MW, molecular weight; PE, phosphatidylethanolamine; PET(CT), positron emission tomography (computed tomography); SPECT(CT), single-photon emission computed tomography (computed tomography).